Assessing the role of advanced artificial intelligence as a tool in multidisciplinary tumor board decision-making for recurrent/metastatic head and neck cancer cases – the first study on ChatGPT 4o and a comparison to ChatGPT 4.0
This research demonstrates that ChatGPT 4o and 4.0 share a similar performance, while ChatGPT 4o is significantly faster. Since the current versions cannot tailor therapy recommendations, and sometimes recommend incorrect treatment options and lack information on the source material, advanced AI models at the moment can merely assist in the MDT setting for recurrent/metastatic HNSCC.
Authors
- Barbara Wollenberg (ORCID: https://orcid.org/0000-0002-3062-459X)
- Markus Wirth (ORCID: https://orcid.org/0000-0001-7240-5363)
- Benedikt Schmidl (ORCID: https://orcid.org/0000-0003-2201-4246)
- Timon Hussain (ORCID: https://orcid.org/0000-0003-4256-232X)
- Steffi Pigorsch (ORCID: https://orcid.org/0000-0001-9824-4828)
- Fabian Stögbauer (ORCID: https://orcid.org/0000-0002-8897-5165)
- Cosima C. Hoch (ORCID: https://orcid.org/0000-0002-3875-7389)
- Tobias Hütten
Institutions
- Technical University of Munich (DE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-05
- DOI
- https://doi.org/10.3389/fonc.2024.1455413
- Citations
- 16
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 1.92